Search company, investor...

Founded Year

2002

Stage

Acquired | Acquired

Total Raised

$80.6M

Valuation

$0000 

About Insight Pharmaceuticals

Insight Pharmaceuticals is a consumer products company that is quietly transforming the over-the-counter (OTC) marketplace. Insight is a privately held company with an aggressive growth strategy built upon the acquisition of a recognizable set of OTC women's health and personal care products. Founded in 1996 with the express mission of acquiring underperforming niche consumer OTC products, Insight has increased targeted acquisitions over the past several years to build a formidable portfolio of solid brands.

Headquarters Location

900 Northbrook Drive Suite 200

Feasterville Trevose, Pennsylvania, 19053,

United States

800-344-7239

Loading...

Loading...

Insight Pharmaceuticals Patents

Insight Pharmaceuticals has filed 4 patents.

The 3 most popular patent topics include:

  • arthropod anatomy
  • colloidal chemistry
  • essential oils
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/30/2021

Food additives, Essential oils, Colloidal chemistry, Arthropod anatomy, Medicinal plants

Application

Application Date

3/30/2021

Grant Date

Title

Related Topics

Food additives, Essential oils, Colloidal chemistry, Arthropod anatomy, Medicinal plants

Status

Application

Latest Insight Pharmaceuticals News

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete's Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene

Feb 2, 2024

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene February 02, 2024 at 09:01 am EST Share TARRYTOWN, N.Y., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling two lots of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid to the consumer level. A recent review by our manufacturer and their third-party lab found that samples from two lots of the product contained elevated levels of benzene. While benzene is not an ingredient in any Ting® Antifungal Spray products, the review showed that unexpected levels of benzene came from the propellant that sprays the product out of the can. Importantly, no other lots of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid (either before or after these batch codes) and no other Ting® Antifungal Spray Liquid products are in the scope of this recall and may continue to be used by consumers safely and as intended. Risk Statement: Benzene is classified as a human carcinogen. Exposure to benzene can occur by inhalation, orally, and through the skin and it potentially can result in cancers including leukemia and blood cancer of the bone marrow and blood disorders which can be life threatening. Insight is recalling these products out of an abundance of caution. To date, the Company has not received any serious adverse events related to this recall. Benzene is ubiquitous in the environment. Humans around the world have daily exposures to it indoors and outdoors from multiple sources. TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid is packaged in blue and white aerosol cans with Lot codes located on the bottom of the can. Samples of the recalled lots below have been found to contain elevated levels of Benzene related to the propellant that sprays the product out of the can. Benzene is not an ingredient in any Ting products. Product 4.5 oz/128 g The affected TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid lots were distributed nationwide in the United States through a limited number of retailers and online. Insight has notified retailers via overnight mail to remove any remaining recalled product from shelves and follow the instructions provided in the Drug Recall Notification. The company will also offer reimbursement for consumers who have purchased TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid marked with one of the lot codes in the table above. Consumers can contact Insight Pharmaceuticals via e-mail at medicalaffairs@prestigebrands.com, through its website at https://www.prestigebrands.com/contact, or by phone at (800) 344-7239 on Monday – Friday 8:30-5:30 eastern time to receive a full refund by providing a picture of the bottom of the can of the TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid with the affected lot number. Consumers that have product which is being recalled should stop using the product immediately and appropriately discard after taking the picture. No serious adverse events have been reported to date. Consumers with questions regarding this recall can contact Insight Pharmaceuticals via e-mail at medicalaffairs@prestigebrands.com, through its website at https://www.prestigebrands.com/contact, or by phone at (800) 344-7239 on Monday – Friday 8:30-5:30 eastern time. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this antifungal product. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax. Complete and submit the report Online: www.fda.gov/medwatch/report.htm Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178. This recall is being conducted with the knowledge of the U.S. Food and Drug Administration. A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4e67b6ae-69a2-4b42-aee6-cff9f651a24a Share

Insight Pharmaceuticals Frequently Asked Questions (FAQ)

  • When was Insight Pharmaceuticals founded?

    Insight Pharmaceuticals was founded in 2002.

  • Where is Insight Pharmaceuticals's headquarters?

    Insight Pharmaceuticals's headquarters is located at 900 Northbrook Drive, Feasterville Trevose.

  • What is Insight Pharmaceuticals's latest funding round?

    Insight Pharmaceuticals's latest funding round is Acquired.

  • How much did Insight Pharmaceuticals raise?

    Insight Pharmaceuticals raised a total of $80.6M.

  • Who are the investors of Insight Pharmaceuticals?

    Investors of Insight Pharmaceuticals include Prestige Brands Holdings, Ares Capital Corporation, Swander Pace Capital and Allied Capital.

  • Who are Insight Pharmaceuticals's competitors?

    Competitors of Insight Pharmaceuticals include Ology Bioservices, Kala Pharmaceuticals, Salix Pharmaceuticals, Peckforton Pharmaceuticals, ANI Pharmaceuticals and 7 more.

Loading...

Compare Insight Pharmaceuticals to Competitors

N
Novast

Novast operates as a generic and specialty pharmaceutical company. It specializes in the research and development (R&D) of generic pharmaceuticals It was founded in 2005 and is based in Nantong, China.

P
Pondera Pharmaceuticals

Pondera Pharmaceuticals is a company focused on the development of health supplements designed to support endorphin balance and stress response. Their main product, Endorphinate®, is formulated to maintain healthy endorphin levels and receptor balance, aiming to provide relief from emotional and physical distress while enhancing energy and mental clarity. It is based in Pownal, Maine.

P
P2D Biosciences

P2D, Inc. is a pharmaceutical company focused on developing new pharmaceuticals for brain disorders

C
Century Pharmaceuticals

Century Pharmaceuticals Ltd is a company focused on the manufacturing of active pharmaceutical ingredients (APIs) and offers a range of related services in the pharmaceutical sector. The company provides contract manufacturing, API development, biotechnology research, and stability studies. Century Pharmaceuticals primarily serves the pharmaceutical and biotechnology industries. It was founded in 1982 and is based in India.

B
BioSentinel Pharmaceuticals

BioSentinel Pharmaceuticals specializes in the development of detection technologies and assays for botulinum neurotoxin (BoNT) within the biotechnology sector. The company offers rapid and sensitive tests that are used for BoNT detection in various applications, including biodefense and pharmaceutical quality control, with a focus on replacing animal testing methods. BioSentinel's products are primarily utilized by government defense agencies and pharmaceutical companies. It is based in Madison, Wisconsin.

A
AviServe

AviServe aims to provide an accurate, contemporary, responsive and science based resource laboratory and consulting service for use by the poultry and allied industries. The company aims to assist clients with the recognition and control of conventional and complex diseases that affect the profitability of the poultry, biologics, diagnostics and animal pharmaceuticals industries. Per the company, they have the ability to develop disease diagnostics and control strategies that can be individualized on a company or geographical basis.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.